⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Lipidomic Biomarkers in Diabetic Distal Symmetrical Polyneuropathy with Conduction Slowing (P8-11.015)

Joseph Wardell Zhao Zhong Chong Kelly Saverino Kazim Jaffry Biji Thomas Philip Tejas Patel Abu Nasar Ankit Pahwa Daniel L. Menkes Nizar Souayah

View Full Paper

Ask AI

Bookmark

Share

Abstract

To identify lipid markers in diabetic distal symmetrical polyneuropathy (DDSP) with conduction slowing (CS).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Wardell et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdadb6db643587677e81 https://doi.org/10.1212/wnl.0000000000204811

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Identification of New Biomarkers in Diabetic Distal Symmetrical Polyneuropathy with Conduction Slowing: A Prospective Proteomics Analysis (P8-11.003)2024
2Clinical and Biological Markers of Conduction Slowing in Diabetic Distal Symmetrical Polyneuropathy: A Prospective Study (P8-11.012)2024
3Serum Lipidomics Profiling Identify Novel Biomarkers of Distal Symmetrical Polyneuropathy in Type 1 Diabetescohort · 2026
4Novel strategy: Identifying new markers for demyelination in diabetic distal symmetrical polyneuropathy2024 · 4 citations
5Is There an Association Between Serum Neurofilament Light Chain Levels and Conduction Slowing in Type 2 Diabetic Distal Symmetrical Polyneuropathy? (P3-4.003)2024